Valuation28 Mar 2024 10:40
Nothing demonstrates the difficulty of private valuation as well as Aiven, the third largest holding. May 21 post money valuation $800M, Oct 21 $2bn, May 22 $3bn. Grow has it at £83m, my guess is they own circa 5%. So they are valuing it correctly at a discount to last round but the private market was on steroids in late 2021 early 2022 and as you can see from all PE listed valuations, SMT good liquid ex at 60% discount on privates if you assume their large publics deserve no discount, MSFT et all. The public markets just think the private market is way over the top, that is why there is a log jam in the capital recycling. On secondaries its a buyers market not a sellers as everyone knows this. Grow spent £311m in21/22 financial year, the largest amount in their history and realised £126m and yes got a £363m FV movement. They are now paying the price. Because they invest mostly in Pref shares which can have many different terms and because of NDAs cannot reveal all the details (and the detailed terms affect valuation) they and shareholders are fighting with their hands tied behind their backs. The information asymmetry makes these unsuitable public vehicles, its that simple. Also they cant return capital until they get much much bigger, otherwise they get diluted when the companies come back for funding which they do regularly in the A/B and seed stage. They have about £70m cash and undrawn £50M to support a portfolio of £1.3bn, there is no chance of a capital return or dividend and they cant sell at a fair price. This is why the people in the market describe conditions as among the worst ever but they caused it themselves by being too exuberant in 2021 and 2022.